Actively Recruiting
Curcumin and Retinal Study
Led by Texas Tech University Health Sciences Center · Updated on 2026-01-13
60
Participants Needed
1
Research Sites
175 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To test how two weeks of curcumin supplementation would cross the blood brain barrier (BBB) and attach to amyloid beta proteins, to assess the feasibility (safety and bioavailability), and to explore the resulting abundance/composition of gut microbiota.
CONDITIONS
Official Title
Curcumin and Retinal Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female between 40 and 89 years old
- Diagnosed with amyloid beta deposits in the retina (peripheral superior quadrants) confirmed within 6 months or by ophthalmic exam after consent
- No existing liver or kidney disease by self-report
You will not qualify if you...
- Have ocular diseases such as macular degeneration or severe diabetic retinopathy
- Used systemic antibiotics within 1 month before starting the study
- Taken turmeric or curcumin products within 2 weeks before starting the study
- Known allergy to black pepper
- Pregnant or breastfeeding women
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Texas Tech University Health Sciences Center
Lubbock, Texas, United States, 79430
Actively Recruiting
Research Team
C
Chwan-Li (Leslie) Shen, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here